- News
- Technical Information

- Advanced equipment and technique
- Experienced scientific team
- Highly reliable and reproducible result
- Data analysis, detailed report with results and discussion
- Quality one-stop service

News

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Bispecific Aptamer Chimeras Degrade Target Proteins On Cell Membranes

Bispecific Aptamer Chimeras Degrade Target Proteins On Cell Membranes

Discovery of molecular glue degraders

Discovery of molecular glue degraders

Nature-CDK inhibitor CR8 acts as a molecular glue degradation agent to kill cancer cells

Nature-CDK inhibitor CR8 acts as a molecular glue degradation agent to kill cancer cells

Nature-Lysosome-targeting chimaeras for degradation of extracellular proteins

Nature-Lysosome-targeting chimaeras for degradation of extracellular proteins

PhosTACs Target Proteins for Dephosphorylation

PhosTACs Target Proteins for Dephosphorylation

PROTAC in the Generation of Live Attenuated Influenza A Virus Vaccine

PROTAC in the Generation of Live Attenuated Influenza A Virus Vaccine

Protein Degradation with New Chemical Modalities: Successful Strategies in Drug Discovery and Chemical Biology

Protein Degradation with New Chemical Modalities: Successful Strategies in Drug Discovery and Chemical Biology

Recent Progress of PROTACs Targeting Non-enzymatic Functional Proteins

Recent Progress of PROTACs Targeting Non-enzymatic Functional Proteins

RIBOTAC technology can target and completely degrade the genome of COVID-19

RIBOTAC technology can target and completely degrade the genome of COVID-19

RIBOTAC: RNA Degradation Technology

RIBOTAC: RNA Degradation Technology

RIPTAC Promises to Overcome Cancer Treatment Resistance

RIPTAC Promises to Overcome Cancer Treatment Resistance

Searching for molecular glue in targeted disease control

Searching for molecular glue in targeted disease control

Second-Generation PROTACs to Achieve Tumor-Specific Targeting

Second-Generation PROTACs to Achieve Tumor-Specific Targeting

Study on the permeability of androgen receptor PROTACs molecules

Study on the permeability of androgen receptor PROTACs molecules

Successful degradation of PD-L1 by Antibody-Based PROTACs Technology

Successful degradation of PD-L1 by Antibody-Based PROTACs Technology

The Development Process of DUBTAC

The Development Process of DUBTAC

The Liposome-Based PROTAC Strategy

The Liposome-Based PROTAC Strategy

We invite you to contact us at or through our contact form above for more information about our services and products.

USA

International:
US & Canada (Toll free):
Email:
Fax:

UK

Email:

Inquiry Basket

Loading ......

Delete selected Go to checkout